NCT04733079View on ClinicalTrials.gov

Treat-to-target by Email During Urate-lowering Therapy in Gout

NAActive, not recruitingINTERVENTIONAL
Enrollment

204

Participants

Timeline

Start Date

December 15, 2021

Primary Completion Date

August 28, 2025

Study Completion Date

August 28, 2025

Conditions
GoutInflammatory RheumatismHyperuricemiaPosology Adjustment
Interventions
OTHER

Cleanweb electronic messaging ePro

Patient and their medecin will communicate regulary via Cleanweb electronic messaging ePro to adapt the posology of THU untill the target urecemia is reached

OTHER

Usual follow-up

Adaptation and follow-up of ULT according to referring physician's habits

Trial Locations (2)

75010

Hopital LARIBOISIERE - Rhumatologie, Paris

Rhumathology department, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER